95 related articles for article (PubMed ID: 4989339)
21. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
Weaver CH; Bensinger WI; Appelbaum FR; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
Bone Marrow Transplant; 1994 Nov; 14(5):813-9. PubMed ID: 7889015
[TBL] [Abstract][Full Text] [Related]
22. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.
Pinguet F; Culine S; Bressolle F; Astre C; Serre MP; Chevillard C; Fabbro M
Clin Cancer Res; 2000 Jan; 6(1):57-63. PubMed ID: 10656432
[TBL] [Abstract][Full Text] [Related]
23. Cancer chemotherapy by intra-arterial infusion with adriamycin.
Di Pietro S; De Palo GM; Gennari L; Molinari R; Damascelli B
J Surg Oncol; 1973 May; 5(5):421-30. PubMed ID: 4795227
[No Abstract] [Full Text] [Related]
24. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
[TBL] [Abstract][Full Text] [Related]
25. [Usual harmlessness of endovesical instillations of thio-tepa].
des Roseaux M; Vacant J; Beurton D; Cukier J
J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):485-7. PubMed ID: 4216647
[No Abstract] [Full Text] [Related]
26. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
[TBL] [Abstract][Full Text] [Related]
27. [Local intra-arterial infusion chemotherapy of malignant tumor--successful treatment by intra-arterial infusion of 5-fluorouracil and mitomycin C in cases of unresectable cancer of the liver, stomach, colon and rectum].
Miura T; Ishida M
Naika; 1971 Jun; 27(6):1275-84. PubMed ID: 5092039
[No Abstract] [Full Text] [Related]
28. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
Madrigal Alonso PL; Perez Gomez FJ
Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
[No Abstract] [Full Text] [Related]
29. Influence of platelet count on haemostatic plug formation and plug stability. An experimental study in rabbits with graded thrombocytopenia.
Bergqvist D; Arfors KE
Thromb Diath Haemorrh; 1973 Dec; 30(3):586-96. PubMed ID: 4787674
[No Abstract] [Full Text] [Related]
30. Thiotepa-induced myelosuppression: review of 670 bladder instillations.
Soloway MS; Ford KS
J Urol; 1983 Nov; 130(5):889-91. PubMed ID: 6415297
[TBL] [Abstract][Full Text] [Related]
31. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
Slack NM; Jones R
Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
[No Abstract] [Full Text] [Related]
32. Cancer chemotherapy by intra-arterial infusion.
SCANLON EF; NORA PF; TARKINGTON JA; MEYER NI
Surg Clin North Am; 1963 Feb; 43():31-8. PubMed ID: 13976506
[No Abstract] [Full Text] [Related]
33. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
Hara J; Osugi Y; Ohta H; Matsuda Y; Nakanishi K; Takai K; Fujisaki H; Tokimasa S; Fukuzawa M; Okada A; Okada S
Bone Marrow Transplant; 1998 Jul; 22(1):7-12. PubMed ID: 9678789
[TBL] [Abstract][Full Text] [Related]
34. Factors responsible for bone marrow toxicity after treatment of myeloma patients with different alkylating agents.
Ringborg U; Lewensohn R
Acta Med Scand; 1978; 203(4):276-8. PubMed ID: 645439
[TBL] [Abstract][Full Text] [Related]
35. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
[TBL] [Abstract][Full Text] [Related]
37. [The effect of anesthesia and surgical intervention on hematopoiesis following chemotherapy of malignant ovarian tumors].
Frid IA; Turbina IL
Vopr Onkol; 1972; 18(2):91. PubMed ID: 4622345
[No Abstract] [Full Text] [Related]
38. [Prediction of peripheral blood leukopenia during tumor chemotherapy].
Kochetkova VA; Ul'chenko VM; Gracheva ZA; Lastochkina VI
Sov Med; 1986; (11):88-90. PubMed ID: 3105092
[No Abstract] [Full Text] [Related]
39. Phase II evaluation of mitozolomide in ovarian cancer.
Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
[No Abstract] [Full Text] [Related]
40. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
